GlassScriptPhysician profile
Amelia Selph
NPI 1053386706
$655.76
in general payments reported to CMS, 2019-2025
13 companies · $294 in 2025
The $294 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $61.75 · 2023: $131 · 2024: $168 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $594.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.98 | 2023-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $82.80 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $80.51 | 2022-2023 | Jynarque |
| Ardelyx, INC. | $76.36 | 2024-2025 | Ibsrela |
| Astrazeneca Pharmaceuticals LP | $70.05 | 2023-2025 | Lokelma |
| Travere Therapeutics, INC. | $52.08 | 2025 | |
| Fresenius USA Marketing, INC. | $37.59 | 2025 | Velphoro |
| Abbvie INC. | $35.90 | 2023-2024 | |
| Calliditas Therapeutics US INC. | $22.15 | 2024 | |
| Vifor Pharma, INC. | $21.85 | 2022 | |
| Scpharmaceuticals INC. | $19.89 | 2025 | |
| Nxstage Medical, INC. | $18.21 | 2022 | |
| Alexion Pharmaceuticals, INC. | $17.39 | 2025 | Ultomiris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amelia Selph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.